BridgeMD
Compares treatment options for Myofascial Neck Pain
Official title Core Stability vs Scapular Stabilization on Hand Grip Strength in Chronic Myofascial Neck Pain
ClinicalTrials.gov ID: NCT07692126
What this study is testing
- What it's testing
- Chronic myofascial neck pain (CMNP) is a painful non-articular musculoskeletal neck syndrome that is a persistent and prevalent with a high incidence of recurrence rate range 30-93%.Management of myofascial trigger points were directed at its deactivation, and prevention of its recurrence. Based on mechanical kinetic chain, the upper extremity functions as a unique system of connected segments those collaborated in a harmony in order to perform daily life activities.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 45
You may be able to join if
- Patients diagnosed with chronic myofascial neck pain depending on referral, and physical examination.
- Sixty patients diagnosed with chronic myofascial neck pain for more than six months.
- Patients age range will 25-45 years
- Patients body mass index (BMI) will be 18.5-24.9 kg/m2
- Each patient suffering from all active MTrPs in the upper trapezius muscle with painful/ tender nodule.
You likely can't join if
- Presence of signs of severe pathology such as malignancies, mainly of the cervical region.
- Fracture of the cervical spine.
- Cervical radiculopathy or myelopathy.
- Diabetes mellitus.
- Trauma, cognitive anomalies, and surgery around neck, shoulders, or hand.
- Fibromyalgia or vascular syndromes such as vertebral basilar insufficiency.
See the full eligibility criteria
- Patients diagnosed with chronic myofascial neck pain depending on referral, and physical examination.
- Sixty patients diagnosed with chronic myofascial neck pain for more than six months.
- Patients age range will 25-45 years
- Patients body mass index (BMI) will be 18.5-24.9 kg/m2
- Each patient suffering from all active MTrPs in the upper trapezius muscle with painful/ tender nodule.
- Patients have a constant neck pain with positive jump sign when palpating the upper trapezius muscle.
- Patients have referred pain, and symptoms of ipsilateral hand muscle weakness.
- No history of undergoing physiotherapy modalities or corticosteroid injection therapies in the past six months before the study
- Presence of signs of severe pathology such as malignancies, mainly of the cervical region.
- Fracture of the cervical spine.
- Cervical radiculopathy or myelopathy.
- Diabetes mellitus.
- Trauma, cognitive anomalies, and surgery around neck, shoulders, or hand.
- Fibromyalgia or vascular syndromes such as vertebral basilar insufficiency.
- Pregnancy.
- Having undergone physical therapy within the past three months before the study.
- Having corticosteroid injection therapies in the past 3 months before the study.
The study team makes the final eligibility decision.
Where it's taking place
- Giza, Giza Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 25 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giza, Giza Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.